Literature DB >> 12519408

Hyperadiponectinaemia in anorexia nervosa.

M L Delporte1, S M Brichard, M P Hermans, C Beguin, M Lambert.   

Abstract

OBJECTIVE: Adiponectin (ApN) is a fat-derived hormone that enhances insulin sensitivity, controls body weight, prevents atherosclerosis and negatively regulates haematopoiesis and immune functions. In contrast to many proteins secreted by adipose tissue, the circulating level of ApN falls in obesity and insulin resistance states. The influence of starvation-induced depletion of fat stores on ApN concentrations is yet unknown. We therefore investigated plasma ApN in anorexia nervosa (AN). PATIENTS AND
DESIGN: We measured plasma ApN in 26 female anorectic patients and examined its relationships to several anthropometric or metabolic parameters. Twenty-four age-matched healthy female controls (C) were also studied.
RESULTS: Body mass index (BMI) and fat mass were markedly decreased in AN. However, plasma ApN levels were 30% higher in anorectic than in control subjects (P < 0.01), while a reverse pattern was observed for leptin concentrations. When normalized for fatness, ApN values almost doubled in AN. ApN levels were negatively correlated with BMI and fat mass (P < 0.05 in the combined population, AN + C). Insulin sensitivity tended to be 40% higher in AN (n = 7) than in C (n = 12) subjects, and plasma ApN levels were positively correlated with insulin sensitivity (P < 0.05 in AN + C subgroups). Total and low density lipoprotein (LDL)-cholesterol were higher, or tended to be higher, in AN, but there were no correlations between plasma ApN and plasma lipids. By contrast, ApN was related to the lipid profile, in a manner consistent with its antiatherogenic role, in healthy controls [i.e. negatively correlated with triglycerides, total and LDL-cholesterol and total/high density lipoprotein (HDL) cholesterol; P < 0.05 or less for each parameter]. In a multiple regression analysis, BMI and insulin sensitivity in AN were independent determinants for ApN levels, explaining up to approximately 80% of the variance in this measure.
CONCLUSIONS: Plasma adiponectin levels are increased in anorexia nervosa. This may, at least in part, be due to the lack of negative feedback exerted by fat mass on adiponectin production and/or to enhanced insulin sensitivity. We speculate that hyperadiponectinaemia could, in turn, contribute to maintain a state of enhanced insulin sensitivity and possibly exacerbate haematological and infectious complications of anorexia nervosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519408     DOI: 10.1046/j.1365-2265.2003.01702.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  33 in total

1.  Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse.

Authors:  Jackie A Fretz; Tracy Nelson; Yougen Xi; Douglas J Adams; Clifford J Rosen; Mark C Horowitz
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

Review 2.  Adiponectin and energy homeostasis.

Authors:  Bonggi Lee; Jianhua Shao
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

3.  Increased lipid and lipoprotein concentrations in anorexia nervosa: A systematic review and meta-analysis.

Authors:  Alia A Hussain; Christopher Hübel; Mathias Hindborg; Emilie Lindkvist; Annie M Kastrup; Zeynep Yilmaz; René K Støving; Cynthia M Bulik; Jan M Sjögren
Journal:  Int J Eat Disord       Date:  2019-03-28       Impact factor: 4.861

4.  Determinants of adiponectin levels in patients with chronic systolic heart failure.

Authors:  Andreia Biolo; Rei Shibata; Noriyuki Ouchi; Shinji Kihara; Mina Sonoda; Kenneth Walsh; Flora Sam
Journal:  Am J Cardiol       Date:  2010-02-20       Impact factor: 2.778

5.  Determinants of plasma adiponectin levels in patients with anorexia nervosa examined before and after weight gain.

Authors:  Anja Bosy-Westphal; Georg Brabant; Verena Haas; Simone Onur; Thomas Paul; Detlef Nutzinger; Harald Klein; Maren Hauer; Manfred J Müller
Journal:  Eur J Nutr       Date:  2005-04-04       Impact factor: 5.614

6.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 7.  Adiponectin in insulin resistance: lessons from translational research.

Authors:  Florencia Ziemke; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

Review 8.  Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Authors:  Nikolaos Spyrou; Konstantinos I Avgerinos; Christos S Mantzoros; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2018-12

9.  Relationship of fat distribution with adipokines in patients with acquired immunodeficiency virus infection.

Authors:  Daniel A de Luis; Pablo Bachiller; Teresa Palacios; Rosa Conde; Olatz Izaola; Beatriz de la Fuente; Jose M Eiros Bouza
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

10.  Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.

Authors:  Jason M Correnti; Egle Juskeviciute; Aditi Swarup; Jan B Hoek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.